by Scott Larrivee | Oct 29, 2024 | Utah, Awards & Honors, Blog
October 29, 2024 – Utah Business’ 2024 class of “Healthcare Heroes” includes one of Nusano’s very own, Greg Moffitt. Greg is the director of Target Development for Nusano. He operates at the forefront of efforts to addressing and solve the...
by Scott Larrivee | Oct 17, 2024 | News
Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...
by Scott Larrivee | Oct 7, 2024 | News
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024. Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in...
by Scott Larrivee | Oct 3, 2024 | News
VALENCIA, Calif. – Oct. 3, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced the addition of two executives to support its business commercialization and the availability of non-carrier-added lutetium-177...
by Scott Larrivee | Oct 1, 2024 | News
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif. – Oct. 1, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C...
